HOME › DRUGS › VALDECOXIB
ACTIVE SUBSTANCE / INN

VALDECOXIB

Brand name(s): Valdyn, Valdyn (previously Kudeq), Bextra, BEXTRA
FDA LISTED
EMA LISTED
WITHDRAWN
DISCONTINUED
Osteoarthritis;Arthritis, Rheumatoid;Dysmenorrhea
NDA021341
ACTIVE SUBSTANCE
Valdecoxib
REGULATORS
FDA · EMA
SPONSORS / MAH
Pfizer Limited, GD SEARLE, Pharmacia - Pfizer EEIG
TOTAL APPLICATIONS
4
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
BEXTRANDA021341GD SEARLEDiscontinued
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
BextraPharmacia - Pfizer EEIGWithdrawn27/03/2003Arthritis, Rheumatoid;Osteoarthritis;Dysmenorrhea
Valdyn (previously Kudeq)Pfizer LimitedWithdrawn27/03/2003Arthritis, Rheumatoid;Osteoarthritis;Dysmenorrhea
ValdynPharmacia Europe EEIGWithdrawn27/03/2003Osteoarthritis;Arthritis, Rheumatoid;Dysmenorrhea

FULL INTELLIGENCE ON VALDECOXIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →